Deepika Pakianathan, Director at OncoMed Pharmaceuticals Inc (OMED), bought 80,203 shares at $18.89 ($1.5M) on 2014-08-19, disclosed to the SEC on 2014-08-21.
Open-market purchase of $1.5M OMED by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.89 | 116 | $2K | 0.1% |
| 2 | $18.89 | 12,425 | $235K | 15.4% |
| 3 | $19.00 | 429 | $8K | 0.5% |
| 4 | $19.00 | 45,630 | $867K | 57.0% |
| 5 | $18.98 | 201 | $4K | 0.3% |
| 6 | $18.98 | 21,402 |
| $406K |
| 26.7% |
| Total | $18.98 avg | 80,203 | $1.5M | 100% |
| Filing → |
| KPTI | SELL | 2024-06-04 | $1.4M | — | Filing → |
| CALA | SELL | 2023-01-31 | $47K | — | Filing → |
| KPTI | SELL | 2022-06-10 | $6.8M | — | Filing → |